Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate (Q45742830)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2000

Language	Label	Description	Also known as
English	Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate	scientific article published in June 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

1 reference

ORCID Public Data File 2021

author name string

Goetsch L

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Plotnicky-Gilquin H

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Champion T

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Beck A

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Corvaïa N

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Stâhl S

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Bonnefoy JY

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Nguyen TN

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Power UF

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

18

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

24

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

2735-2742

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of BALE/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and characterization of Respiratory Syncytial Virus protein G related peptides containing two disulfide bridges

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Progenitors for Ly-1 B cells are distinct from progenitors for other B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Origin of murine B cell lineages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900057-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(00)00057-8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10781861

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45742830&oldid=2079932014"